Athira Pharma, Inc. (ATHA)
NASDAQ (CM) NASDAQ (CM) Primary 
Athira Pharma's Alzheimer's drug fails in mid-to-late stage trial
Athira Pharma said on Tuesday its investigative drug failed to meet the main goal in a mid-to-late stage trial in patients with mild-to-moderate Alzheimer's disease.
ATHA Energy identifies new mineralized trends at Angilak uranium project
ATHA Energy Corp (CSE:SASK, OTCQB:SASKF) announced it has completed its 2024 Exploration Program at its Angilak uranium project in Nunavut, which hosts the Lac 50 uranium Deposit. The “highly successful” program was carried out from early June to late August and involved 25 diamond drill holes totalling about 10,051 meters.
ATHA Energy advances exploration at Gemini and Angilak uranium projects
ATHA Energy Corp (CSE:SASK, OTCQB:SASKF) has provided investors with an update on its 2024 exploration programs at its uranium projects. At its Gemini project in the Athabasca Basin, Saskatchewan, the company in late August kicked off a Phase 3 diamond drill program to expand the footprint of mineralization, targeting the down-dip extents of the Gemini Mineralized Zone (GMZ).
Are Medical Stocks Lagging Athira Pharma (ATHA) This Year?
Here is how Athira Pharma, Inc. (ATHA) and HCA Healthcare (HCA) have performed compared to their sector so far this year.
ATHA Energy signs LOI for joint venture on Canadian uranium projects
ATHA Energy Corp (CSE:SASK, OTCQB:SASKF) announced on Tuesday that it has signed a non-binding letter of intent (LOI) with Australian-listed Terra Uranium Ltd (ASX:T92) for a potential joint venture on key uranium exploration projects in Saskatchewan's Athabasca Basin. The proposed deal involves an option for Terra Uranium to acquire a 70% interest in ATHA's Spire and Horizon properties, while ATHA could gain up to a 60% stake in Terra Uranium's Pasfield Lake property.
Is Athira Pharma (ATHA) Stock Outpacing Its Medical Peers This Year?
Here is how Athira Pharma, Inc. (ATHA) and HCA Healthcare (HCA) have performed compared to their sector so far this year.
Athira (ATHA) Completes Dosing in Alzheimer's Study, Stock Up
Athira (ATHA) completes dosing the last patient in the phase II/III LIFT-AD study on fosgonimeton for treating people with mild-to-moderate Alzheimer's disease. Stock gains.
ATHA Energy expands uranium footprint at Angilak
ATHA Energy Corp (CSE:SASK, OTCQB:SASKF) said its 2024 exploration program at the Angilak project has successfully expanded the uranium mineralization footprint with a 100% hit rate. The company updated on the progress of its 2024 exploration program at the Nunavut project, with the first six drill holes successfully expanding the footprint of uranium mineralization outside the historic Lac 50 Uranium Deposit.
ATHA Energy director's machine learning innovation recognized by Future Explorer's Competition
ATHA Energy Corp (CSE:SASK, OTCQB:SASKF) announced that its Director Geodata Drew Heasman, who leads its Digital Discovery team, has been awarded the top prize at the 2023/2024 Future Explorer's Competition. Organized by Humyn AI and funded by Dundee Precious Metals, the Future Explorer's Competition began in November 2023 and brings together more than 200 data scientists and geoscientists from 37 countries.
ATHA Energy commences 2024 Angilak diamond drilling program
ATHA Energy Corp (CSE:SASK, OTCQB:SASKF) has commenced Phase I of its 2024 Angilak Diamond Drilling Exploration Program at its Angilak Project in Nunavut. The program involves around 10,000 meters of diamond drilling, targeting the expansion of high-grade uranium mineralization at the Lac 50 Deposit and adjacent zones.
ATHA Energy enters option agreement with Riverboat Energy for Vista property in Athabasca Basin
ATHA Energy Corp (CSE:SASK, OTCQB:SASKF) has signed an option agreement with Riverboat Energy Corporation, granting Riverboat the exclusive option to acquire a 70% interest in ATHA's Vista property in the Athabasca Basin. The agreement, effective May 20, 2024, allows Riverboat to earn the interest by fulfilling specified cash payments, share issuances, and exploration expenditures on the Vista property.
